BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Dubai
BEGIN:STANDARD
TZOFFSETFROM:+0400
TZOFFSETTO:+0400
TZNAME:+04
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20200308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20201101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20210314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20211107T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20220313T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20221106T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Krasnoyarsk
BEGIN:STANDARD
TZOFFSETFROM:+0700
TZOFFSETTO:+0700
TZNAME:+07
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20210722T160000
DTEND;TZID=UTC:20210722T180000
DTSTAMP:20260611T191445
CREATED:20210716T030816Z
LAST-MODIFIED:20210716T032053Z
UID:2147-1626969600-1626976800@thebiocalendar.com
SUMMARY:Entrepreneur Spotlight: The Pennsylvania Biotechnology Center's annual "Shark Tank" style event
DESCRIPTION:Join us for a unique networking event\, which is free of charge\, to watch ‘Shark-Tank’ style pitches from three new startup companies located at the Pennsylvania Biotechnology Center (PABC)\, followed by breakout sessions for each company. The three companies are: (1) EcoGenome\, a life science company dedicated to the development of prognostic and predictive tests that will enhance personalized treatment strategies for cancer patients\, to improve outcomes\, and reduce costs; (2) Mid-Atlantic Bio\, which is working to bring novel immunotherapies to market\, targeting multiple infectious disease indications with high unmet medical need\, like rabies and coronaviruses; and (3) Gene Lancet Biosciences\, a gene-editing company that owns a novel guide RNA (lgRNA) of distinct intellectual property designed for use in RNA-guided endonucleases as gene editing tools and human therapeutics.
URL:https://thebiocalendar.com/event/entrepreneur-spotlight-the-pennsylvania-biotechnology-centers-annual-shark-tank-style-event/
LOCATION:CA\, United States
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/07/Small-Spotlight-image.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210722T100000
DTEND;TZID=UTC:20210722T110000
DTSTAMP:20260611T191445
CREATED:20210714T210156Z
LAST-MODIFIED:20210714T210156Z
UID:2131-1626948000-1626951600@thebiocalendar.com
SUMMARY:Accelerating Structure Based Drug Design for Challenging Proteins by CryoEM
DESCRIPTION:For decades now\, X-ray crystallography has been the go-to technique to unravel structural details of proteins\, in pursuit of answering various biological questions and aiding structure based drug design. However\, in the last few years\, cryo-Electron Microscopy (cryoEM) has garnered a lot of attention and is quickly advancing towards being the most effective and powerful macromolecular structure determination tool due its ability to the otherwise challenging samples such as large protein complexes\, flexible proteins with multiple conformations\, viruses\, and membrane proteins. Various technological advancements in the last decade with respect to detector quality\, detector speed\, data collection and processing speed\, automation in software\, improvements in sample preparation\, footprint of the microscope\, and more affordability has also enabled many large pharmaceuticals and smaller biotechs taking up cryoEM as the first choice tool for structure determination. The scientific community marveled at the recent Nature article that reported a 1.2A cryoEM structure of apoferritin\, clearly showing not just water molecules\, but other polar and nonpolar hydrogens as well. With this resolution revolution\, cryoEM has opened the doors to a lot more research projects which have been trying X-ray crystallography without much success. Here we are presenting a few recently published high resolution cryoEM structures including those of SARS-CoV2\, how this tool has been advancing in the last few years\, how the new breakthroughs have brought about a resolution revolution once again\, and how we are democratizing cryoEM by bringing it to the masses.
URL:https://thebiocalendar.com/event/accelerating-structure-based-drug-design-for-challenging-proteins-by-cryoem/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210722T083000
DTEND;TZID=America/New_York:20210723T163000
DTSTAMP:20260611T191445
CREATED:20210701T232728Z
LAST-MODIFIED:20210702T001124Z
UID:2088-1626942600-1627057800@thebiocalendar.com
SUMMARY:Chief Patient Officer Summit
DESCRIPTION:DGE invites you to its inaugural Chief Patient Officer Summit – the only industry event to specifically focus on opportunities and challenges facing Chief Patient Officers and executives focused on building the best possible patient experience. From identifying unmet patient needs in discovery research… to accelerating greater diversity and inclusion in clinical trials… to ensuring affordable access and patient support\, the CPO Summit provides depth and breadth of the critical issues and path forward.
URL:https://thebiocalendar.com/event/chief-patient-officer-summit/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/07/iStock-965851348-1-min-952x579-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210721T113000
DTEND;TZID=UTC:20210721T130000
DTSTAMP:20260611T191445
CREATED:20210714T210059Z
LAST-MODIFIED:20210714T210059Z
UID:2130-1626867000-1626872400@thebiocalendar.com
SUMMARY:Facilities/EH&S Workshop: Spotlight on Fremont
DESCRIPTION:Join Biocom California and the City of Fremont on July 21st to hear from a panel of industry leaders on why life science is booming in Fremont\, initiatives to recruit local talent\, the industry’s evolution\, and how companies in Fremont will contribute to future life science growth in the Bay Area.
URL:https://thebiocalendar.com/event/facilities-ehs-workshop-spotlight-on-fremont/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210721T100000
DTEND;TZID=UTC:20210721T230000
DTSTAMP:20260611T191445
CREATED:20210714T205931Z
LAST-MODIFIED:20210714T205931Z
UID:2129-1626861600-1626908400@thebiocalendar.com
SUMMARY:Industry Insights: Inclusive Onboarding
DESCRIPTION:How can you ramp up your new employee experience by implementing inclusive onboarding and transition practices at your organization? Join Slone Partners and Biocom California for a timely interactive discussion where we will share best practices and tangible tools to help your organization develop an inclusive experience to onboard and retain top talent. The extent to which organizations make new hires feel welcomed and fully prepared to contribute\, the faster they will become productive members of the team and the more likely they will be to remain with the company over the long term. This discussion will focus on strategies\, ideas\, and case studies you can use to develop a diverse company and create an inclusive workspace for all.
URL:https://thebiocalendar.com/event/industry-insights-inclusive-onboarding/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210721
DTEND;VALUE=DATE:20210723
DTSTAMP:20260611T191445
CREATED:20210602T230643Z
LAST-MODIFIED:20210602T230643Z
UID:1981-1626825600-1626998399@thebiocalendar.com
SUMMARY:2021 Peptide Drug Design & Delivery Virtual Summit
DESCRIPTION:Are you looking to improve the performance of your peptide drug products? Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions. \nThe 2021 Peptide Drug Design & Delivery Summit will bring together key decision-makers and innovators within this rapidly growing field. This intensive 2-Day program will examine various peptide discovery and synthesis techniques and synthesized and modified peptides. Hear from over 30 peptide drug commercialization experts on a variety of sessions including peptide engineering\, peptidomimetics\, peptide conjugation\, and cell-penetrating peptides for molecular imaging. \nAdditionally\, 2021’s Summit will examine novel strategies for improving peptide stability and half-life\, along with novel routes of administration. Case studies will be presented that illustrate the progress made in developing efficacious peptide therapeutics\, while leaders in the field point the way to the future for these promising drugs. Meet and network with 100’s of drug development professionals and walk away with over 2 years of new peptide commercialization strategies in just 2 days!
URL:https://thebiocalendar.com/event/2021-peptide-drug-design-delivery-virtual-summit/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210720T130000
DTEND;TZID=UTC:20210720T150000
DTSTAMP:20260611T191445
CREATED:20201004T022217Z
LAST-MODIFIED:20210507T165047Z
UID:838-1626786000-1626793200@thebiocalendar.com
SUMMARY:Mental health and biotech
DESCRIPTION:Although there has been a gradual change over the past 20 years in the recognition and public acceptance of the importance of mental health problems\, there is a persistent translational gap between preclinical research and psychiatric treatment. Novel strategies are being implemented to utilise technology and AI to detect\, monitor\, and treat mental health issues. In this event\, we will discuss how we might use AI and other technologies to aid clinicians in diagnosis and treatment; to improve patient safety; and to recognise early on the acute worsening of mental states. \n 
URL:https://thebiocalendar.com/event/mental-health-and-biotech/
ATTACH;FMTTYPE=image/svg+xml:https://thebiocalendar.com/wp-content/uploads/2020/10/logo_innoforum.svg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210720T090000
DTEND;TZID=UTC:20210722T130000
DTSTAMP:20260611T191445
CREATED:20210218T012823Z
LAST-MODIFIED:20210625T195245Z
UID:1826-1626771600-1626958800@thebiocalendar.com
SUMMARY:LIFE SCIENCES FUTURE - MEDTECH
DESCRIPTION:Life Sciences Future – MedTech will be held over a 3-day period using a robust web-based platform that includes both live and on demand features. All company presentations will be pre-recorded and loaded into the platform prior to the event. The conference will include the most popular conference features\, but will focus on various topics within the medical device\, diagnostics\, and digital health industries. \nLocation: Virtual
URL:https://thebiocalendar.com/event/life-sciences-future-medtech/
CATEGORIES:Featured
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/02/med3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210716T153000
DTEND;TZID=UTC:20210716T193000
DTSTAMP:20260611T191445
CREATED:20210602T230129Z
LAST-MODIFIED:20210602T230129Z
UID:1977-1626449400-1626463800@thebiocalendar.com
SUMMARY:SoCalBio Innovation Catalyst Program
DESCRIPTION:This meeting is one of many screening forums organized by SoCalBio to select the best device\, biotech\, and digital health company candidates to make presentations during: \n\nThe 23rd Annual SoCalBio Conference on October 20-22\, 2021\n5th SoCalBio Digital Health Conference on March 23-25\, 2022
URL:https://thebiocalendar.com/event/socalbio-innovation-catalyst-program-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20210716T120000
DTEND;TZID=Asia/Dubai:20210716T130000
DTSTAMP:20260611T191445
CREATED:20210625T053040Z
LAST-MODIFIED:20210625T053313Z
UID:2069-1626436800-1626440400@thebiocalendar.com
SUMMARY:Finding Talent in a Competitive Marketplace
DESCRIPTION:How do you turn great science into a great business? By pooling the efforts and expertise of talented individuals. During this panel we’ll explore how to:\n• Identify and prioritize the skills and expertise needed to grow a life science business\n• Strategies for finding and attracting the right hires\n• Creative approaches to tapping professional expertise\n• Regional workforce initiatives and training programs geared towards the life sciences industry
URL:https://thebiocalendar.com/event/finding-talent-in-a-competitive-marketplace/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/06/BioSP_Generic_Email_Header_with-logos_updated0421.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210716T080000
DTEND;TZID=UTC:20210716T170000
DTSTAMP:20260611T191445
CREATED:20210716T201502Z
LAST-MODIFIED:20210716T201502Z
UID:2153-1626422400-1626454800@thebiocalendar.com
SUMMARY:"The Beginning and End of COVID-19" presented by Moderna's Dr. Randall Hyer
DESCRIPTION:Join us for this FREE\, virtual event!\nRandall Hyer\, MD\, PhD\, MPH Senior Vice President at Moderna Therapeutics\, Inc. will be presenting on the topic “The Beginning and End of COVID-19.” This event is free of charge but pre-registration is required.
URL:https://thebiocalendar.com/event/the-beginning-and-end-of-covid-19-presented-by-modernas-dr-randall-hyer-3/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/07/Randall-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210715T180000
DTEND;TZID=UTC:20210715T190000
DTSTAMP:20260611T191445
CREATED:20210616T173434Z
LAST-MODIFIED:20210616T173434Z
UID:2044-1626372000-1626375600@thebiocalendar.com
SUMMARY:Unstoppable: The Future of Biotech & Digital Health Investing
DESCRIPTION:COVID-19 has ignited biotech and digital health investment activity – from telemedicine to drug trial technology to precision genomics. In 2020\, biotech IPO’s continued to pique investor interest and venture capital fundraising in healthcare reached record levels- and 2021 shows no sign of abating. According to Crunchbase\, there has been $4.1B+ in health-related investment deals this year to date. \nWhile the pandemic has accelerated new innovations that are disrupting healthcare\, the pace of change will continue well into the future. \nJoin our panelists for a dynamic discussion on the emerging technologies that are changing healthcare as we know it\, reflect on this past year’s funding trends\, and where investors will be placing their bets in the future. \nMEET THE HOST: \n\nDenyse Cardozo — Executive Director\, Silicon Valley Forum
URL:https://thebiocalendar.com/event/unstoppable-the-future-of-biotech-digital-health-investing/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20210715T113000
DTEND;TZID=America/Denver:20210715T130000
DTSTAMP:20260611T191445
CREATED:20210617T234429Z
LAST-MODIFIED:20210617T234429Z
UID:2058-1626348600-1626354000@thebiocalendar.com
SUMMARY:PBSS Free Online Seminar: Statins for Cholesterol Control: Historical Stories and Lessons Learned
DESCRIPTION:Speaker: Jie Jack Li\, PhD has practiced medicinal chemistry since 1997 at Pfizer\, BMS\, and Revolution Medicines\, respectively\, with a four-year sojourn at the University of San Francisco as an Associate Professor\, teaching organic and medicinal chemistry. He is currently a vice president of Discovery Chemistry at ChemPartner\, splitting his time between San Francisco and Shanghai. He has published 30 books in organic chemistry\, medicinal chemistry\, and history of drug discovery. His 2014 book\, Blockbuster Drugs\, won the 2015 Alpha Sigma Nu Science Book Award and his latest book is\, Medicinal Chemistry for Practitioners.\nThis mini-symposium is part of the PBSS series “Historical Stories and Lessons Learned”.
URL:https://thebiocalendar.com/event/pbss-free-online-seminar-statins-for-cholesterol-control-historical-stories-and-lessons-learned/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/06/PBSS-logo-SFBayai-1-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210714T163000
DTEND;TZID=UTC:20210714T190000
DTSTAMP:20260611T191445
CREATED:20210616T172523Z
LAST-MODIFIED:20210616T172523Z
UID:2036-1626280200-1626289200@thebiocalendar.com
SUMMARY:BVS' Summer Biotech Community Celebration at Tech Square in Cambridge
DESCRIPTION:We are very excited to announce our outdoor Summer Biotech Community Event at the Tech Square Courtyard. \nAll the biotech tenants at 100-500 Technology Square and other companies in the Cambridge vicinity will be invited to attend this event. \nThe event is being promoted as a special Biotech Community Event sponsored by the best scientific suppliers in the industry along with it being a wonderful way for scientists and science vendors to network in a relaxed evening venue. \nThe event will be a combination of vendor exhibits\, food\, beer & wine. We will have extra special raffle prizes and expect an excellent turnout. \nWe are looking forward to seeing everyone.
URL:https://thebiocalendar.com/event/bvs-summer-biotech-community-celebration-at-tech-square-in-cambridge/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20210713T183000
DTEND;TZID=Asia/Krasnoyarsk:20210713T203000
DTSTAMP:20260611T191445
CREATED:20210608T213448Z
LAST-MODIFIED:20210608T213448Z
UID:2000-1626201000-1626208200@thebiocalendar.com
SUMMARY:The pivotal role of CMC in the drug approval process
DESCRIPTION:Solid state chemistry\, polymorphic forms of the drug and the ability to scale up manufacturing are very important details that define the identity as well as feasibility of a drug. Very minor changes in any or each of these aspects of the drug can pivot chances of scale up\, or a process to launch or acquire approval. Things change on the brink of scale up and manufacturing for commercialization to almost derail approval and this talk will feature case studies in this area. \nEvent Location:\nZoom talk: https://us02web.zoom.us/j/88274227563
URL:https://thebiocalendar.com/event/the-pivotal-role-of-cmc-in-the-drug-approval-process/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210713T130000
DTEND;TZID=UTC:20210713T140000
DTSTAMP:20260611T191445
CREATED:20210616T173135Z
LAST-MODIFIED:20210616T173135Z
UID:2039-1626181200-1626184800@thebiocalendar.com
SUMMARY:Insights: Immunotherapy – Helping Our Bodies Cure Cancer
DESCRIPTION:Community Relations Special Event Partnership \nImmunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer. \nImmunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer. This evolving form of therapy is designed to prime the body’s own immune system to fight the disease head-on. Doctors report promising results\, including tough-to-treat tumors melting away. For some patients\, such as those with melanoma and lung cancer\, immunotherapy has increased survival rates from months to years. \nHowever\, the treatment doesn’t work for everyone\, and even when it does work initially\, it can lose effectiveness as time goes on. Why do some people respond to treatments and others do not? Which cancers respond best to immunotherapy?\nJoin us to hear from those on the leading edge of immunotherapy research: \n\nHow does immunotherapy work?\nWhy do some cancers turn “blind eye” to immunotherapy?\nWhat does the future hold for expanding the benefit of immunotherapy to more patients?\n\nA Q&A session will follow the presentation and will give you an opportunity to personally connect with our scientists and have your questions answered. \nDon’t miss this chance to connect with our scientists and have your questions answered!
URL:https://thebiocalendar.com/event/insights-immunotherapy-helping-our-bodies-cure-cancer/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210713
DTEND;VALUE=DATE:20210715
DTSTAMP:20260611T191445
CREATED:20210617T193753Z
LAST-MODIFIED:20210617T193754Z
UID:2049-1626134400-1626307199@thebiocalendar.com
SUMMARY:2021 STAT Breakthrough Science Summit
DESCRIPTION:Come here for the cutting edge\n\nTechnologies and procedures that would have been science fiction are now the reality of medicine. Our 2021 STAT Breakthrough Science Summit will take you inside these innovations\, examining how they’re being developed\, adopted\, and paid for. We’ll also take a look at the breakthroughs that haven’t yet hit the market\, but have the potential to redefine health and medicine in the years to come.
URL:https://thebiocalendar.com/event/2021-stat-breakthrough-science-summit/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/06/download.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210712T080000
DTEND;TZID=UTC:20210714T170000
DTSTAMP:20260611T191445
CREATED:20201001T235202Z
LAST-MODIFIED:20201001T235202Z
UID:767-1626076800-1626282000@thebiocalendar.com
SUMMARY:Biotech CEO Summit
DESCRIPTION:Held annually in Napa and Europe\, the Biotech CEO Summits provide high-value\, relationship-building opportunities through informal discussions where personal knowledge\, insights\, and ideas are exchanged with peers. These candid discussions take place in a secure\, confidential setting. \nWho Participates\nBiotech CEO Summits are limited to CEOs focused on leading their organizations through the ever-evolving biotech landscape\, transforming individual companies and the industry as a whole. Non-CEO participants include a select group of industry leaders. \nAbout the Program\nThe program includes fireside chats\, case studies and group discussions that address a range of global issues key to biotech CEOs and their companies. The Summit format facilitates engagement\, discussion and interaction with and between all CEOs. The topics are identified in consultation with the advisory board\, and include discussions on strategy (asset selection\, collaborations\, market approach)\, financing (public and private)\, communications to all audiences (shareholders\, investors\, board of directors\, patients\, regulatory bodies\, and team)\, human resources (board and team development and management)\, and lessons learned during make or break situations. \nParticipant Benefits\nAn important benefit of participating in the Summit is the development of trusted relationships between CEOs and the select group of other industry thought leaders. The program is designed to ensure all CEOs spend quality time together. Everyone is encouraged to participate in the candid discussions\, to share their experiences and to ask questions. All CEOs are invited to suggest topics for discussion. Throughout the Summit\, networking sessions\, dinners and activities provide opportunities for CEOs to meet one-on-one and build relationships.
URL:https://thebiocalendar.com/event/biotech-ceo-summit/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/10/download-12.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210710
DTEND;VALUE=DATE:20210712
DTSTAMP:20260611T191445
CREATED:20210602T225917Z
LAST-MODIFIED:20210602T225917Z
UID:1976-1625875200-1626047999@thebiocalendar.com
SUMMARY:2021 BTBA Virtual Annual Symposium
DESCRIPTION:Hosted by Boston Taiwanese Biotechnology Association (BTBA) for biotech professionals in academia or industry to learn and connect virtually \n\n\n\n\n\n\n\n\nBoston Taiwanese Biotechnology Association (BTBA) will hold the 2021 BTBA Virtual Annual Symposium from 12:50 pm to 6:30 pm EDT on July 10 & 11 (Saturday and Sunday) 2021. \nThis online symposium will bring experts from academia and industry to share their experiences and knowledge on their research/responsibility\, personal career development\, and lessons learned for young scientists. This year\, we are honored to have Dr. Herren Wu\, Ph.D.\, the Senior Vice President of AstraZeneca\, and Dr. Jeannie T. Lee\, M.D.\, Ph.D.\, Professor of Genetics of Harvard Medical School \nPlease register on Eventbrite where you will then receive information on how to join the meeting virtually. \nThe event is free. \nAs a non-profit organization\, we appreciate your consideration of giving a small gift to support BTBA! Your donation qualifies for tax-exemption and grants you guaranteed access to the 2021 BTBA Virtual Symposium meeting rooms. \nBTBA Website : https://btbatw.org/ \n2021 BTBA Virtual Symposium website: https://btbatw.org/2021/
URL:https://thebiocalendar.com/event/2021-btba-virtual-annual-symposium/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210708T120000
DTEND;TZID=UTC:20210708T130000
DTSTAMP:20260611T191445
CREATED:20210602T225817Z
LAST-MODIFIED:20210602T225817Z
UID:1975-1625745600-1625749200@thebiocalendar.com
SUMMARY:ADDC Webinar Series on Bioentrepreneurship: "Cell Therapy"
DESCRIPTION:Join us for breakfast\, lunch\, or cocktails in your local time zone for our monthly webinar series on bioentrepreneurship.\n\n\n\n\n\n\n\nIn this “Things I Wish I Knew” series\, we will learn from prominent scientists\, entrepreneurs\, and investors about their successes\, struggles\, and the things they wished they knew before starting their journey. \n“CELL THERAPY” \n\n\nThis Seminar series is hosted by the Academic Drug Discovery Consortium (ADDC). The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies\, universities\, and government agencies that support and partner with these centers.
URL:https://thebiocalendar.com/event/addc-webinar-series-on-bioentrepreneurship-cell-therapy/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210707T160000
DTEND;TZID=UTC:20210707T170000
DTSTAMP:20260611T191445
CREATED:20210602T230234Z
LAST-MODIFIED:20210602T230234Z
UID:1978-1625673600-1625677200@thebiocalendar.com
SUMMARY:QB3 Webinar: David Baker\, University of Washington
DESCRIPTION:Billions of years of evolution have proteins that perform incredibly specialized functions. But evolution must take a continuous path. What if\, given all we now know about how structure relates to function\, we could shortcut evolution and custom-design proteins for our own aims? We can. In this talk\, David Baker of the University of Washington’s Institute for Protein Design will describe how his group designs and fabricates enzymes\, motor proteins\, biologics delivery vehicles\, and other sophisticated macromolecules from first principles. \nAbout the Speaker \nDavid Baker is the director of the Institute for Protein Design\, a Howard Hughes Medical Institute Investigator\, the Henrietta and Aubrey Davis Endowed Professor in Biochemistry\, and an adjunct professor of genome sciences\, bioengineering\, chemical engineering\, computer science\, and physics at the University of Washington. His research group is focused on the design of macromolecular structures and functions. \nHe received his Ph.D. in biochemistry with Randy Schekman at the University of California\, Berkeley\, and did postdoctoral work in biophysics with David Agard at UCSF.
URL:https://thebiocalendar.com/event/qb3-webinar-david-baker-university-of-washington/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210707T150000
DTEND;TZID=UTC:20210707T160000
DTSTAMP:20260611T191445
CREATED:20210602T225707Z
LAST-MODIFIED:20210604T024046Z
UID:1974-1625670000-1625673600@thebiocalendar.com
SUMMARY:Startup Legal Bootcamp Series with Matt Crowley - Networking with Investors
DESCRIPTION:Networking with Investors – From Getting a Business Card to Getting the Check\nWednesday\, July 7\, 2021\, 3-4pm \nMystified about how startups raise funds? Listen to an experienced venture lawyer walk participants through the process of finding and meeting angel investors and venture capitalists.
URL:https://thebiocalendar.com/event/startup-legal-bootcamp-series-with-matt-crowley-networking-with-investors/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210706
DTEND;VALUE=DATE:20210709
DTSTAMP:20260611T191445
CREATED:20210610T193953Z
LAST-MODIFIED:20210610T193953Z
UID:2021-1625529600-1625788799@thebiocalendar.com
SUMMARY:Venture Summit Virtual Connect | Global 21
DESCRIPTION:Venture Summit Virtual Connect | Global 21\, presented by youngStartup Ventures\, is the premier industry gathering connecting venture capitalists\, corporate VCs\, angel investors\, technology transfer professionals\, senior executives of venture backed\, emerging and early stage companies\, university researchers\, incubators and premier service providers. Whether you are an investor seeking access to new deals\, or founder and/or CEO of a new venture looking for funding\, visibility and growth\, Venture Summit Virtual Connect | Global 21 is one event you won’t want to miss.
URL:https://thebiocalendar.com/event/venture-summit-virtual-connect-global-21/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/06/LogoNew-e1620234514716.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210630T150000
DTEND;TZID=UTC:20210630T160000
DTSTAMP:20260611T191445
CREATED:20210602T225615Z
LAST-MODIFIED:20210602T225615Z
UID:1973-1625065200-1625068800@thebiocalendar.com
SUMMARY:Startup Legal Bootcamp Series with Matt Crowley - Marriage and Divorce for Co-Founders
DESCRIPTION:Marriage and Divorce for Co-Founders\nWednesday\, June 30\, 2021\, 3-4pm \nThinking about partnering up with colleagues to start your first business? Learn about time-tested strategies for getting the co-founder relationship off to a healthy start.
URL:https://thebiocalendar.com/event/startup-legal-bootcamp-series-with-matt-crowley-marriage-and-divorce-for-co-founders/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210630T110000
DTEND;TZID=UTC:20210630T120000
DTSTAMP:20260611T191445
CREATED:20210602T230822Z
LAST-MODIFIED:20210602T231403Z
UID:1982-1625050800-1625054400@thebiocalendar.com
SUMMARY:Berkeley Lab 90th Anniversary - Virtual Tour of the Joint Genome Institute (June)
DESCRIPTION:In 2021\, Berkeley Lab’s 90th year\, we’re celebrating past achievements and imagining tomorrow’s solutions. As part of this celebration we are highlighting our facilities like never before! In this pre-scheduled\, live\, interactive\, presentation by Lab staff and scientists you will learn about the Joint Genome Institute. \nThe mission of the U.S. Department of Energy (DOE) Joint Genome Institute (JGI)\, a DOE Office of Science User Facility of Berkeley Lab\, is to advance genomics in support of the DOE missions related to clean energy generation and environmental characterization and cleanup. Supported by the DOE Office of Science\, the JGI unites the expertise at Berkeley Lab\, Lawrence Livermore National Laboratory\, and the HudsonAlpha Institute for Biotechnology. During this virtual tour\, you will learn how JGI provides integrated high-throughput sequencing\, DNA design and synthesis\, metabolomics and computational analysis that enable systems-based scientific approaches to these challenges. \nJoin a Zoom Webinar for approximately 60 minutes including a live presentation and Q&A!
URL:https://thebiocalendar.com/event/berkeley-lab-90th-anniversary-virtual-tour-of-the-joint-genome-institute-june/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210630T090000
DTEND;TZID=UTC:20210630T100000
DTSTAMP:20260611T191445
CREATED:20210608T233657Z
LAST-MODIFIED:20210608T233657Z
UID:2001-1625043600-1625047200@thebiocalendar.com
SUMMARY:California Life Sciences: Conversation with Thought Leaders: Health Equity
DESCRIPTION:Join California Life Sciences for our Conversation with Thought Leaders: Health Equity\, which will explore the importance of increasing health access to underserved communities\, overcoming vaccine hesitancy. We’ll also explore how the life sciences community can help tackle other hurdles to ensure equitable and safe health care access for patients and their families.
URL:https://thebiocalendar.com/event/california-life-sciences-conversation-with-thought-leaders-health-equity/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/06/251288_CLS_Thought_LI-FB.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210629T170000
DTEND;TZID=UTC:20210629T193000
DTSTAMP:20260611T191445
CREATED:20210616T172744Z
LAST-MODIFIED:20210616T172744Z
UID:2038-1624986000-1624995000@thebiocalendar.com
SUMMARY:BVS' Biotech Community Event at the Green Flash Brewery
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at the Green Flash Brewery. \nThese events are always very popular and we get representation from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. \nThe event is being promoted as a special Biotech Community Event sponsored by the best scientific suppliers in the industry along with it being a wonderful way for scientists and science vendors to network in a relaxed evening venue. \nThe event will be a combination of vendor exhibits\, tacos and beer. We will have extra special raffle prizes and expect an excellent turnout. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-the-green-flash-brewery/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210629T130000
DTEND;TZID=UTC:20210629T140000
DTSTAMP:20260611T191445
CREATED:20210623T221214Z
LAST-MODIFIED:20210623T221216Z
UID:2067-1624971600-1624975200@thebiocalendar.com
SUMMARY:Benefits of System Validation for Life Sciences Companies
DESCRIPTION:Join RSM Senior Director\, Michael Breggar\, and Director\, Steve Kemler\, to learn how a pragmatic computer system validation can be beneficial for your entire organization. Many people view regulatory compliance activities as something that simply “has to be done;” however\, there are also many areas of value add along this transformational path. What if you took the process of validation as a way to improve and streamline your operations? \nJoin the RSM team to see a demonstration of how our Life Sciences clients are improving their businesses while also meeting regulatory requirements; often times leveraging the leading cloud-based ERP – NetSuite.
URL:https://thebiocalendar.com/event/benefits-of-system-validation-for-life-sciences-companies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/06/custom_logoImageFile.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210628T160000
DTEND;TZID=UTC:20210628T180000
DTSTAMP:20260611T191445
CREATED:20210616T184456Z
LAST-MODIFIED:20210616T184456Z
UID:2048-1624896000-1624903200@thebiocalendar.com
SUMMARY:SoCalBio Networking Forum: COVID-9; Accelerator / Disrupter / Game-Changer?
DESCRIPTION:When COVID-19 hit last year\, it unveiled many of the vulnerabilities of the US healthcare system and its supply chain. In the process\, it also gave a second life to the search for pathways to institutionalize a value-based healthcare regime to improve patient outcomes and reduce the cost of care. \nJoin us for an inspiring keynote presentation to be followed by a lively discussion of the long-term impact of COVID\, and how innovators in the Medtech\, biotech\, and digital health industries can play a role in driving the transformation to a value-based healthcare system. \nAbout Richard Gannotta: \nRichard Gannotta\, NP\, DHA\, FACHE is a recognized leader in the health sector. He is the Chief Healthcare Administrative Officer at Masimo\, a global technology company that develops and manufactures a variety of innovative noninvasive patient monitoring technology and clinical solution sets designed to improve patient outcomes and reduce the cost of care.
URL:https://thebiocalendar.com/event/socalbio-networking-forum-covid-9-accelerator-disrupter-game-changer/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210623T160000
DTEND;TZID=UTC:20210623T190000
DTSTAMP:20260611T191445
CREATED:20210609T034741Z
LAST-MODIFIED:20210609T034743Z
UID:2009-1624464000-1624474800@thebiocalendar.com
SUMMARY:Venture Capital 101
DESCRIPTION:If you are interested in learning more about how VC investing works\, what their process is for engaging with a life science startup\, and how they manage their portfolios; then you will not want to miss our next event. Please join us on June 23rd from 4-5PM EDT for a talk with Riley Rodgers from Valia Ventures as he explains the ins and outs of VC investing followed by open networking from 5-7PM EDT via the Grapevine Network. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://thebiocalendar.com/event/venture-capital-101/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2021/06/Purple-Zodiac-Sign-Animated-Presentation-4.jpg
END:VEVENT
END:VCALENDAR